- Home
- AGRO vs EYPT Comparison
AGRO vs EYPT Comparison
Compare AGRO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGRO | EYPT |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2011 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AGRO | EYPT |
|---|---|---|
| Price | $12.66 | $13.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $12.80 | ★ $31.80 |
| AVG Volume (30 Days) | ★ 1.6M | 852.2K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,539,000.00 |
| Revenue This Year | $45.90 | N/A |
| Revenue Next Year | N/A | $3,115.57 |
| P/E Ratio | $37.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.89 | $5.46 |
| 52 Week High | $15.89 | $19.11 |
Technical Indicators
Market Signals| Indicator | AGRO | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 46.88 |
| Support Level | $7.67 | $13.61 |
| Resistance Level | $15.89 | $14.54 |
| Average True Range (ATR) | 0.74 | 0.62 |
| MACD | -0.29 | 0.03 |
| Stochastic Oscillator | 24.65 | 47.10 |
Price Performance
Historical ComparisonAbout AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.